---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-215218"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-09-06T23:59:59+00:00"
generated_at: "2026-05-31T06:01:35.484897+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics receives Nasdaq delisting notice; plans appeal to stay listing

## Summary
- Nasdaq notified on Sept 5, 2024 that company failed to regain compliance with minimum $2.5M stockholders' equity rule.
- Company intends to timely appeal, which automatically stays suspension/delisting pending hearing.
- Prior disclosure: stockholders' equity was ($1.348M) as of Dec 31, 2023.
- No assurance that Nasdaq Hearings Panel will grant continued listing or extension.

## SEC filing metadata
- accession: 0001193125-24-215218
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-09-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312524215218/0001193125-24-215218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312524215218/d821033d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-215218
- JSON: https://secwatch.observer/filing/0001193125-24-215218.json
- Plain text: https://secwatch.observer/filing/0001193125-24-215218.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.